73 related articles for article (PubMed ID: 12209613)
1. Value of tenascin-C content and association with clinicopathological parameters in uterine cervical lesions.
Buyukbayram H; Arslan A
Int J Cancer; 2002 Aug; 100(6):719-22. PubMed ID: 12209613
[TBL] [Abstract][Full Text] [Related]
2. Tenascin expression in intraepithelial neoplasia and invasive carcinoma of the uterine cervix.
Iskaros BF; Koss LG
Arch Pathol Lab Med; 2000 Sep; 124(9):1282-6. PubMed ID: 10975921
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
[TBL] [Abstract][Full Text] [Related]
4. Increased presence of stromal myofibroblasts and tenascin-C with malignant progression in canine mammary tumors.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
Vet Pathol; 2011 Jan; 48(1):313-21. PubMed ID: 20571146
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
Hindermann W; Berndt A; Borsi L; Luo X; Hyckel P; Katenkamp D; Kosmehl H
J Pathol; 1999 Dec; 189(4):475-80. PubMed ID: 10629546
[TBL] [Abstract][Full Text] [Related]
6. Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells.
Terasawa K; Furumoto H; Kamada M; Aono T
Cancer Res; 1996 May; 56(9):2229-32. PubMed ID: 8616877
[TBL] [Abstract][Full Text] [Related]
7. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
Tiitta O; Happonen RP; Virtanen I; Luomanen M
J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
[TBL] [Abstract][Full Text] [Related]
8. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.
Atula T; Hedström J; Finne P; Leivo I; Markkanen-Leppänen M; Haglund C
Anticancer Res; 2003; 23(3C):3051-6. PubMed ID: 12926160
[TBL] [Abstract][Full Text] [Related]
10. Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance.
Ishihara A; Yoshida T; Tamaki H; Sakakura T
Clin Cancer Res; 1995 Sep; 1(9):1035-41. PubMed ID: 9816077
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
12. The basement membrane and tumor progression in the uterine cervix.
Nair SA; Nair MB; Jayaprakash PG; Rajalekshmy TN; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Jun; 142(5-6):297-303. PubMed ID: 9228252
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of matrix metalloproteinase-2, cathepsin D, and tenascin-C expression in colorectal carcinoma.
Sis B; Sağol O; Küpelioğlu A; Sokmen S; Terzi C; Fuzun M; Ozer E; Bishop P
Pathol Res Pract; 2004; 200(5):379-87. PubMed ID: 15239346
[TBL] [Abstract][Full Text] [Related]
14. Tenascin pattern of expression and established prognostic factors in invasive breast carcinoma.
Iskaros BF; Hu X; Sparano JA; Fineberg SA
J Surg Oncol; 1998 Jun; 68(2):107-12. PubMed ID: 9624040
[TBL] [Abstract][Full Text] [Related]
15. Tenascin in human neoplasia.
Shrestha P; Kusakabe M; Mori M
Int J Oncol; 1996 Apr; 8(4):741-55. PubMed ID: 21544422
[TBL] [Abstract][Full Text] [Related]
16. Appearance and distribution of stromal myofibroblasts and tenascin-C in feline mammary tumors.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Takahashi K
Histol Histopathol; 2011 Mar; 26(3):297-305. PubMed ID: 21210342
[TBL] [Abstract][Full Text] [Related]
17. [Expression of extracellular matrix glycoprotein tenascin in the laryngeal cancer].
Zhang S; Liu Q; Liu Z; Hua X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2002 Dec; 16(12):643-5. PubMed ID: 12669429
[TBL] [Abstract][Full Text] [Related]
18. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
Booth C; Harnden P; Selby PJ; Southgate J
J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269
[TBL] [Abstract][Full Text] [Related]
19. Cellular sources of tenascin-C in canine mammary carcinomas.
Yoshimura H; Michishita M; Ohkusu-Tsukada K; Matsuda Y; Ishiwata T; Naito Z; Takahashi K
Vet Pathol; 2015 Jan; 52(1):92-6. PubMed ID: 24565830
[TBL] [Abstract][Full Text] [Related]
20. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.
Ioachim E; Michael MC; Salmas M; Damala K; Tsanou E; Michael MM; Malamou-Mitsi V; Stavropoulos NE
BMC Cancer; 2006 May; 6():140. PubMed ID: 16732887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
